en
Scientific article
French

Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L'étude suisse de cohorte VIH

Published inSchweizerische medizinische Wochenschrift, vol. 126, no. 43, p. 1845-1848
Publication date1996
Abstract

Zidovudine (ZDV) was the most widely used anti-HIV drug between 1987 and 1995, and, as already reported, transmission of ZDV-resistant viruses occurs. Several mutations of the reverse transcriptase gene have been identified; one of them affects the 215 codon and is associated with a high degree of resistance. We have determined, using selective PCR, the prevalence of transmission of 215 mutant isolates in 134 patients with primary HIV infection (PHI) and have identified 8 patients with 215 mutant virus between 1989 and 1995 in Switzerland. Mutant resistant viruses have been isolated from patients treated with most antiviral drugs. A systematic search for mutant viruses may provide useful information for the adaptation of treatment strategies.

Keywords
  • Adolescent
  • Adult
  • Antiviral Agents/ pharmacology
  • Base Sequence
  • DNA, Viral/genetics
  • Drug Resistance/genetics
  • Female
  • HIV/ drug effects/genetics
  • HIV Infections/ transmission
  • HIV Reverse Transcriptase/genetics
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Zidovudine/ pharmacology
Citation (ISO format)
YERLY FERRILLO, Sabine et al. Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L’étude suisse de cohorte VIH. In: Schweizerische medizinische Wochenschrift, 1996, vol. 126, n° 43, p. 1845–1848.
Identifiers
ISSN of the journal0036-7672
512views
0downloads

Technical informations

Creation07/12/2010 2:37:24 PM
First validation07/12/2010 2:37:24 PM
Update time03/14/2023 3:54:49 PM
Status update03/14/2023 3:54:49 PM
Last indexation01/15/2024 8:53:40 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack